Our in vitro results validate that the pharmacological inhibition of ACSL4 by ROSI is as same effective as ACSL4 knockdown in ameliorating tubular ferroptosis and antagonizing renal fibrosis, but it cannot be excluded that ROSI may be involved in regulating kidney fibrosis by modulating PPARγ activity57. This evidence concerns the gene PPARG and renal fibrosis.